Clinical Trials · NCT05613387
A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Zealand Pharma
- Enrollment
- 68
- Start date
- Nov 2022
- Locations
- 1 site, Germany
- Primary endpoint
- Incidence of treatment emergent adverse events (TEAEs)